ANDA Submissions-Content and Format
Guidance for Industry By Global Compliance Seminar (LinkedIn; Twitter) ANDA Submissions-Content and Format of Abbreviated New Drug Applications June 2014 Generics This guidance is intended to assist...
View ArticleQuestions and Answers for ANDAs Stability Testing
FDA Guidance for Industry ANDAs: Stability Testing of Drug Substances and Products: Questions and Answers May 2014 This guidance provides answers to questions from the public (more…)
View ArticleANDA Submissions – Refuse-to-Receive Standards
Guidance for Industry By Global Compliance Seminar (LinkedIn; Twitter) ANDA Submissions – Refuse-to-Receive Standards May 2015 Generic Drugs Revision 1 This guidance is intended to assist applicants...
View ArticleFDA ANDA Submissions-Content and Format
Guidance for Industry ANDA Submissions-Content and Format of Abbreviated New Drug Applications This guidance is intended to assist applicants in preparing abbreviated new drug applications (more…)
View ArticleFDA Guidance for Generic Asthma Drugs
FDA Guidance for Industry Draft Guidance on Fluticasone Propionate; Salmeterol Xinafoate Active ingredient: Fluticasone Propionate; Salmeterol Xinafoate Form/Route: Powder/Inhalation Recommended...
View Article